HOFBF
Hofseth BioCare ASA·Healthcare
0.17
0.000%(+0.00)
Market ClosedLast Updated: — ET
52W L: $0.1552W H: $0.18
HOFBF NEWS
globenewswire.com
Mar 27
Hofseth BioCare ASA: HBC ANNUAL REPORT 2025
The Board of Directors of Hofseth BioCare ASA ("HBC") has approved the financial statements for 2025, and HBC has today published the Annual Report and Sustainability Report for 2025. In October 2025, the Company announced a successful placing of new ordinary shares with gross proceeds of NOK 158 million. As of the date of this Annual report, the Company has yet to receive all share deposits and has therefore not completed the transaction. The primary cause of the delay is stated to be of a technical and legal nature relating to the main investor who has repeatedly expressed its intention to swiftly complete the transaction. The Board therefore expects the transaction to be completed in Q2 2026. The proceeds of the transaction will materially strengthen the Company's balance sheet and support ongoing growth momentum.
globenewswire.com
Feb 13
Hofseth BioCare ASA: FOURTH QUARTER 2025 FINANCIAL REPORT
HBC recorded total operating revenues of NOK 72.2 million in the fourth quarter of 2025, compared to NOK 64.9 million in the same period last year. Net operating revenues were NOK 71.1 million, up from NOK 64.9 million in Q4 2024. Full year 2025, total operating revenues amounted to NOK 256.3 million (265.5). Total operating revenue in 2024 included NOK 8.1 million of gain on sale of assets.
